baber/WOPTO huggingface dataset:
Patent NZ-273736-A (NZ)
Title: Packaging machine, for moving articles such as cans into containers, having adjustable width guides
Inventor: MONCRIEF FRANK
IPC: B65B59/00
Filed: 1994-08-11
Abstract: A continuous motion, end loading packaging machine forms article groups of a predetermined number and configuration using a flight type article selector. The packaging machine is flexible in its ability to package articles of different heights and diameters in various product configurations. The packaging machine includes adjustable guide rails to selectively change product infeed lane widths. The machine also phase adjusts the selector flights, and allows for easy selector flight replacement.
Patent NZ-309457-A (NZ)
Title: Hydrolysis and photocleavage of nucleic acid using texaphyrin
Inventor: MAGDA DARREN
IPC: A61K41/00
Filed: 1996-05-31
Abstract: A particular class of metal complexes, specifically certain texaphyrin metal complexes shown in the formula above, which both hydrolyze and photocleave ribonucleic acid is described. Wherein, M is a divalent or trivalent metal cation;  R1-R4, R7 and R8 are independently H, halide, OH, alkyl, alkenyl, alkynyl, aryl, haloalkyl, nitro, formyl, acyl, hydroxyalkyl, oxyalkyl, oxyhydroxyalkyl, hydroxyalkenyl, hydroxyalknyl, saccharide, carboxy, carboxyalkyl, carboxyamide, carboxyamidealkyl, amino, aminoalkyl, a site-directing molecule, a catalytic group, or a couple to a site-directing molecule or to a catalytic group;  R6 and R9 are independently selected from R1-R4, R7 and R8, with the proviso that the halide is not iodide and the haloalkyl is other than iodoalkyl;  R5 and R10-R12 are independently H, alkyl, alkenyl, alkynyl, aryl, hydroxyalkyl, oxyalkyl, oxyhydroxyalkyl, hydroxyalkenyl, hydroxyalknyl, carboxyalkyl, carboxyamide, carboxyamidealkyl, amino, aminoalkyl, or a couple to a saccharide, to a site-directing molecule or to a catalytic group; and  Z is an integer value less than or equal to 5. The texaphyrin metal complex for each set of reactions has catalytic activity for phosphate ester hydrolysis and is photosensitive. The photocleavage reaction occurs between 650-900 nm of the spectral range. A complex having the advantage of multiple activities can result in lower treatment dosages and lower treatment costs.
Patent NZ-313340-A (NZ)
Title: Mouthpiece, on outer end of spray tube, to atomize liquid which is fed to the spray tube under pressure
Inventor: NILSON BILLY
IPC: B05B1/34
Filed: 1996-07-04
Abstract: PCT No. PCT/SE96/00910 Sec. 371 Date Oct. 2, 1996 Sec. 102(e) Date Oct. 2, 1996 PCT Filed Jul. 4, 1996 PCT Pub. No. WO97/07897 PCT Pub. Date Mar. 6, 1997The present invention relates to a spray mouthpiece arranged on the outer free end of a spray tube. The mouthpiece is adapted by means of intersecting flow passages to atomize liquid which is fed to the spray tube under pressure. The arrangement according to the invention comprises an elongated sleeve which is adapted to be carefully placed on the free end of the spray tube. The sleeve is designed with an end face on which is a centrally located mouthpiece opening. In the sleeve is a cylindrical body connecting to the end face. The body has grooves with which the sleeve forms at least two ducts communicating with the tube. From the tube end, the ducts run approximately axially up to the end face. By means of the intersecting flow passages formed on the end face of the body, the ducts are connected to a chamber that connects to the mouthpiece opening.
Patent NZ-314258-A (NZ)
Title: Two ply bag comprising an inner ply contained within, but removable from, an outer ply
Inventor: WOOD ALEXANDER CHARLES
IPC: B65D30/10
Filed: 1998-02-13
Abstract: ackaging such as a block-base sack (201) suitable for packing of particulate material has an inner bag (not shown) having two layers of polyethylene, surrounded by an outer bag (201) having three layers of polyethylene.  Each bag has a closed bottom and an open top (208) prior to filling.  After filling of the inner bag, the inner bag is closed by a first heat seal along zone (205) in a heat sealing operation which can be performed through the outer bag (201) in such a way that the outer bag (201) is not heat sealed to the inner bag at that point. The outer bag (201) is closed by a second seal (207) located between the first seal (205) and the top of the bag (208).  A frangible zone (206) may be located between the first (205) and second (207) heat seals to enable the outer bag (201) to be removed from the sealed inner bag by cutting or tearing along the frangible zone (206).
Patent NZ-328329-A (NZ)
Title: Treatment of antibiotic associated diarrhea using oligosaccharides
Inventor: HEERZE LOUIS D
IPC: A61K47/36
Filed: 1995-02-09
Abstract: An oligosaccharide sequence covalently attached to a pharmaceutically acceptable solid inert support through a non-peptidyl compatible linker arm can be used in a treatment for antibiotic associated diarrhea, including Clostridium difficile associated diarrhea (CDAD) and psuedomembranous colitis (PMC). Specifically, the oligosaccharide construct can be used to neutralise C.difficile toxin A associated with CDAD. The preferred linker arm is -(CH2)8C(O)- and the selected oligosaccharide sequence is one capable of binding to toxin A.  Examples of solid supports which can be used include silica, porous glass, diatomaceous earth, kaolinite, polystyrene, polypropylene, and polysaccharides.
Patent NZ-330624-A (NZ)
Title: 4-Substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists
Inventor: BIGGE CHRISTOPHER F
IPC: C07D211/28
Filed: 1996-12-20
Abstract: Disclosed are 4-substituted piperidine analogs, pharmaceutical compositions containing the same and the method of using 4-substituted piperidine analogs as selective active antagonists of N-methyl-D-aspartate (NMDA) receptor subtypes for treating conditions such as stroke, cerebral ischemia, central nervous system trauma, hypoglycemia, psychosis, anxiety, migraine headaches, glaucoma, CMV retinitis, aminoglycoside antibiotics-induced hearing loss, convulsions, chronic pain, opioid tolerance or withdrawal, urinary incontinence or neurodegenerative disorders, such as lathyrism, Alzheimer's Disease, Parkinsonism and Huntington's Disease.  The compounds are generally represented by the formula (I) where Ar and Ar' each are optionally substituted aryl or heteroaryl; z is a single or double bond; X is (CHR)m, O, S or NR (where m is 0, 1 or 2 and R is H, OH or alkyl); R1 is H or OH; each R2 is H, OH or alkyl; n is 0, 1, 2, 3 or 4; Y is O, S, NR4 or a bond; and R5 is H or OH.
Patent NZ-331427-A (NZ)
Title: Functional barrier in oxygen scavenging film comprising polyethylene terephthate glycol or amphorous nylon
Inventor: BANSLEBEN DONALD A
IPC: C08L77/00
Filed: 1997-03-07
Abstract: An article of manufacture in the form of a film, a polymeric barrier coating or a gasket, comprising an oxygen scavenger, an oxygen barrier and a polymer selected from the group consisting of polyethylene terephthalate glycol (PETG) and amorphous nylon. A package can be made from this article for containing an oxygen-sensitive article such as food. The described polymers reduce or block the migration of odor causing by-products of an oxygen scavenging process. A method of making an article of manufacture having reduced migration of by-products of an oxygen scavenging reaction includes providing an article including an oxygen scavenger and the above-described polymer; and exposing the article to actinic radiation.
Patent NZ-332719-A (NZ)
Title: Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases
Inventor: WATTS JEFFREY L
IPC: A61K31/496
Filed: 1997-05-05
Abstract: method of classifying waste materials is claimed.  The method comprises arranging two sieve screens 13, 14, each having an inlet end 9 and an outlet end 12, one above the other to define a space therebetween, the upper screen 13 being of coarser mesh size than the lower screen 14; supplying waste material to be classified to the inlet end of the upper screen, vibrating the screens; blowing air between the screens from the inlet end towards the outlet end whereby the waste material is separated into a plurality of fractions with fine material passing downwards through the lower screen 14 under gravity, light material being blown away from the outlet ends of the screens, and large heavy material falling under gravity from the outlet end of the upper screen 13; and separately collecting the separated waste material fractions.  A portion of the upper screen 13 is agitated relatively vigorously as compared to the remainder of the upper screen.  Apparatus for carrying out the method described above is also claimed.  Divisional filed as 336873
Patent NZ-334260-A (NZ)
Title: Arachidonic acid and docosahexanoic acid for treating dyspraxia in children
Inventor: HORROBIN DAVID FREDERICK
IPC: A61K31/202
Filed: 1997-08-26
Abstract: Arachidonic acid (AA) and docosahexanoic acid (DHA) can be used alone or in combination, in a medicament for treating dyspraxia in children aged between birth and one year.  The medicament may also be used for prophylaxis of dyspaxia by administration to pregnant women. Precursors to the acids may also be used in the medicament.  These include linoleic acid, gamma-linolenic acid and dihomo-gamma-linolenic acid for AA, and alpha-linolenic acid, stearidonic acid, eicosapentaenoic acid for DHA.
Patent NZ-334609-A (NZ)
Title: Use of inhibitors of the beta isozyme of protein kinase C for treatment of sexual dysfunctions in mammals
Inventor: JIROUSEK MICHAEL R
IPC: C07D498/22
Filed: 1997-08-22
Abstract: A method for treating sexual dysfunctions is disclosed, particularly using the isozyme selective PKC inhibitor, (S)-3,4-[N,N'-1,1'-((2''-ethoxy)-3'''(O)-4'''-(N,N-dimethylamino)-butane)-bis-(3,3'-indolyl)]-1(H)-pyrrole-2,5-dione, particularly its hydrochloride, or mesylate salt.
Patent NZ-335362-A (NZ)
Title: A teatcup liner and a method of manufacturing a teatcup liner
Inventor: PETTERSON TORBJORN KARL INGEMA
IPC: A01J5/08
Filed: 1997-11-04
Abstract: A teatcup liner (1) which is intended for being mounted in a teatcup shell (2) comprises a tubular head portion (4) forming a passage for receiving a teat. The passage extends between a first and a second axial end of the tubular head portion. The tubular head portion has an annular lip (8), which in the mounted as well as the non-mounted state of the teatcup liner (1) extends radially inwardly from the tubular head portion. Furthermore, the teatcup liner comprises a tubular shaft portion (5), which extends from a second axial end (7) of the head portion, and a member (14), which is arranged to provide a radially outwardly directed pretension in the lip in the mounted as well as the non-mounted state of the teatcup liner (1), and is located outside said passage. A method of manufacturing such a teatcup liner comprises the steps of moulding the teatcup liner, expanding the head portion, and providing the pretensioning member.
Patent NZ-501566-A (NZ)
Title: Pyrimidinyl-piperazinylalkylazole derivatives having anxiolytic and/or tranquilising properties useful for treatment of nausea
Inventor: MERCE-VIDAL RAMON
IPC: C07D233/68
Filed: 1998-05-28
Abstract: A process for the preparation of 2-{4-[4-(4,5-dichloro-2-methyl-imidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimidine characterised by: a) reaction of 8-(5-fluoro-2-pyrimidinyl)-8-aza-5-azoniaspiro[4.5]decane with 4,5-dichloro2-methyl-1H-imidazole in the presence of potassium carbonate and in a dipolar aprotic solvent, such as dimethylformamide. The reaction temperature varying between 70°C and the reflux temperature of the solvent being possible with a reaction time between 3 and 48 hours; b) reaction of 5-fluoro-2- (piperazin-1-yl)-pyrimidine with 1-(4-chlorobutyl)-4,5-dichloro-2-methyl-1H-imidazole in the presence of potassium carbonate and in a dipolar aprotlc solvent, such as dimethylformamide. The reaction temperature varying between 70°C and the reflux temperature of the solvent with a reaction time between 3 and 48 hours (this reaction can also be carried out under phase transfer conditions by using an aqueous sodium hydroxide solution, toluene and a catalyst, such as tetrabutylammonium bromide; under these conditions, the temperature of the reaction can vary between 50°C and 90°C, and the reaction time varies between 12 and 72 hours); c) reaction of 2-{4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]piperazin-1-yl}-5-fluoropyrimidine and of a physiologically acceptable acid, such as citric acid, in an appropriate solvent, such as ethanol. The compound may be used for the treatment of vertigo, travel sickness (nausea), depression, anxiety, gastric acid secretion, obsessive or compulsive disorders, panic attacks and sleep apnea.
Patent NZ-502684-A (NZ)
Title: Solution phase synthesis of phosphorothioate triesters
Inventor: REESE COLIN BERNARD
IPC: C07H21/02
Filed: 1998-08-10
Abstract: A process for the synthesis in solution phase of a phosphorothioate triester is provided. The process comprises the solution phase coupling of an H-phosphonate with an alcohol in the presence of a coupling agent to form an H-phosphonate diester. The H-phosphonate diester is oxidised in situ with a sulfur transfer agent to produce the phosphorothioate triester. Preferably, the H-phosphonate and alcohol are protected nucleosides or oligonucleotides. Oligonucleotide H-phosphonates which can be used in the formation of phosphorothioate triesters are also provided
Patent NZ-505213-A (NZ)
Title: Revetment block with interlocking tips and channel on opposed sides whereby the interlocking tips engage in the respective channel in an adjacent revetment block , the interlocking tips are configured to permit relative movement between the block and adjacent blocks
Inventor: KNIGHT DAVID W
IPC: E02B3/14
Filed: 1999-10-21
Abstract: A revetment block 11 for use in a revetment system composed of the revetment blocks arranged to form a mat. The block 11 has a top surface, a bottom surface and first and second opposed side surfaces13, 14 that extend between the top and bottom surfaces, and third and fourth opposed side surfaces extending between the top and bottom surfaces and the first and second side surfaces. The first and second opposing side surfaces 13, 14 have a mating recess 20 and projection 23, such that a recess 20 on a first side surface mates with a projection on a second side surface 23 of an adjacent block in a revetment system. On each of the third and fourth sides is a channel 25, 30 and two interlocking tips 26, 28, 32, 34 disposed on either side of the channel. The interlocking tips of a third or fourth side of one block are adapted to fit into the channel of the third or fourth side of another block. The interlocking tips and channel are configured so that there is lateral movement when the blocks are configured into a mat.
Patent NZ-507646-A (NZ)
Title: Method for isolation and modification of proteins
Inventor: SAVOLAINEN JOUKO
IPC: A23J1/20
Filed: 1999-04-28
Abstract: A method for modification and isolation of a protein containing a disulfide bond, wherein: (a) a protein is brought into contact with a reagent that forms sulfite ions in order to sulfonate the protein without using an oxidizing agent, and (b) the protein once sulfonated is precipitated at an acid pH, and (c) the precipitated and/or soluble sulfonated protein is recovered and optionally processed further.
Patent NZ-512763-A (NZ)
Title: Trip system for an electrical switch having a favourable force-path-characteristic
Inventor: HEMMER ALOYSIUS GERARDUS MAJEL
IPC: H01H71/32
Filed: 2000-01-06
Abstract: Trip system for an electric switch, comprising a yoke of magnetic material, consisting of a yoke base part, a first yoke leg and a second supporting yoke leg, said first and second yoke legs extending at a mutual spaced relation and in the same direction from the yoke base part, an armature from magnetic material bridging the free ends of the yoke legs and supporting pivotably by the supporting yoke leg, a permanent magnet provided such that its magnetic field lines extend through the yoke and the armature, a coil mounted on the yoke and spring means engaging the armature. The armature is held in a first position under influence of a magnetic field of the permanent magnet in opposite direction of the spring force of the spring means, in which the armature engages the free end of the first yoke leg. The armature may assume a second position under influence of the magnetic field developed by a current flowing through the coil and exceeding a predetermined limit value, in which surfaces facing to each other of the armature and the free end of the first yoke leg are spaced by a first air gap distance. The magnet is included in a second magnetic circuit formed by a yoke and the armature and having in the first position of the armature a magnetic reluctance higher than that of the first magnetic circuit and which increases when the armature moves from the first to the second position.
Patent NZ-513692-A (NZ)
Title: Method and diagnostic kit for diagnosis of endometriosis
Inventor: HUGO PATRICE
IPC: G01N33/53
Filed: 2000-01-24
Abstract: The invention relates to a method and a kit for the diagnosis of endometriosis using blood and endometrial leukocyte markers or a combination thereof. The marker is a surface antigen from endometrial or blood leukocytes.
Patent NZ-514103-A (NZ)
Title: LktA deletion mutant of P. haemolytica
IPC: A23L35/00
Filed: 1998-09-25
Abstract: Described are isolated and purified P. haemolytica bacteria, which express a deletion mutant leukotoxin that induces antibodies that neutralize biologically active leukotoxin.  The bacteria contain a temperature sensitive plasmid, which replicates at 30oC but not 40oC and have an origin of replication obtained by mutation of a pD80 origin of replication of a 4.3 kb ampicillin-resistance plasmid of P. haemolytica serotype NADC D80.
Patent NZ-514300-A (NZ)
Title: Method for conditioning a liquid in a receptacle fitted with a positive pressure valve
Inventor: GRUNDMANN JOACHIM
IPC: F17C13/04
Filed: 2000-04-05
Abstract: Disclosed is a method for conditioning a receptacle which can contain a pressurized liquid, e.g. a gas cylinder, whereby said receptacle is fitted with a positive pressure valve into which a gas with a water or water vapour content of less than 40ppmv is introduced after the internal volume, i.e. the inside, of the receptacle has been dried in order to remove any water vapour therein. A receptacle conditioned in such a way can be used in a welding operation, especially TIG, MIG or MAG welding, or in a plasma-arc cutting operation.
Patent NZ-514493-A (NZ)
Title: Method of seaming and expanding amorphous patterns
Inventor: MCGUIRE KENNETH STEPHEN
IPC: D21H27/02
Filed: 2000-04-06
Abstract: The present invention provides a method for creating amorphous patterns based on a constrained Voronoi tesselation of 2-space that can be tiled. There are three basic steps required to generate a constrained Voronoi tesselation of 2-space: 1) nucleation point placement; 2) Delauney triangulation of the nucleation points; and 3) polygon extraction from the Delauney triangulated space. The tiling feature is accomplished by modifying only the nucleation point poriton of the algorithm. The method of the present invention, for creating an amorphous two-dimensional pattern of interlocking two-dimensional geometrical shapes having at least two opposing edges which can be tiled together, comprises the steps of: (a) specifying the width xmax of the pattern measured in direction x between the opposing edges; (b) adding a computational border region of width B to the pattern along one of the edges located at the x distance xmax; (c) computationally generating (x, y) coordinates of a nucleation point having x coordinates between 0 and xmax; (d) selecting nucleation points having x coordinates between 0 and B and copying them into the computational border region by adding xmax to their x coordinate value; (e) comparing both the computationally generated nucleation point and the corresponding copied nucleation point in the computational border against all previously generated nucleation points; and (f) repeating steps (c) through (e) until the desired number of nucleation points has been generated. To complete the pattern formation process, the additional steps of: (g) performing a Delaunay triangulation on the nucleation points; and (h) performing a Voronoi tessellation on the nucleation points to form two-dimensional geometrical shapes are included. Patterns having two pairs of opposing edges which may be tiled together may be generated by providing computional borders in two mutually orthogonal coordinate directions.
Patent NZ-515513-A (NZ)
Title: Method for treating chronic obstructive pulmonary disease using an endothelin A receptor antagonist
Inventor: KELLER LAURENCE HARVEY
IPC: C07D417/04
Filed: 2001-11-15
Abstract: Chronic obstructive pulmonary disease is treated with a selective ETA receptor antagonist such as 4-(7-ethyl-1,3-benzodioxol-5-yl)-2-[2-trifluoromethyl)phenyl]-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxide or a pharmaceutically acceptable salt thereof.
Patent NZ-518726-A (NZ)
Title: Method of treating or inhibiting neutrophil chemotaxis by administering a mek inhibitor
Inventor: BARAGI VIJAYKUMAR MAHALINGAPPA
IPC: A61K31/365
Filed: 2002-05-02
Abstract: A MEK inhibitor and a phosphatidylinositol-3-kinase (PI3K) inhibitor are used in the manufacture of a medicament for inhibiting neutrophil migration in a subject. Preferably the PI3K inhibitor is wortmannin, benzo[b]thiophene-2-carboxamide or 5,6-dimethoxy-3-phenoxy-N-1H-tetrazol-5-yl and the MEK inhibitor is 2-(2-chloro-4-iodo-phenylamino)-N-cyclopropylmethoxy-3,4-difluro-benzamide. The neutrophil mediated disease is preferably selected from ischemia reperfusion injury, chronic obtrusive pulmonary disease (COPD), acute respiratory disease syndrome, cystic fibrosis, idiopathic pulmonary fibrosis, sepsis, endotoxemia, emphysema and asbestosis.
Patent NZ-520026-A (NZ)
Title: Method and system of customer data visualisation using a series of icons to represent an individual customer's interactions with a merchant
Inventor: CARDNO ANDREW JOHN
IPC: G07F17/30
Filed: 2002-07-05
Abstract: A customer data visualization system comprises: interaction data maintained in computer memory representing interactions between customers and merchants; a retrieval device configured to retrieve from computer memory interaction data involving an individual customer; obtaining, from the retrieved interaction data, customer data associated with the individual customer; an icon generator configured to generate and display at least one variable icon and a plurality of fixed icons representing at least part of the customer data, the at least variable icon including at least one customer value indicator.
Patent NZ-520355-A (NZ)
Title: Pteridine compounds for the treatment of psoriasis
Inventor: BONNERT ROGER
IPC: C07D513/04
Filed: 2001-02-20
Abstract: A compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof; a process for the preparation a the compound; a pharmaceutical composition comprising the compound; and the use of the compound in the manufacture of a medicament for the treatment of a chemokine mediated disease.
Patent NZ-520838-A (NZ)
Title: Fluorescent whitening agent formulation for detergents
Inventor: MERKLE GERHARD
IPC: D06L3/12
Filed: 2001-03-15
Abstract: A fluorescent whitening agent formulation for use in detergents, comprising 20-40% of a compound of formulas 2-5, 10-80% glycerine, 5-70% water.